Latest Articles
Blood cancer: Man left with broken neck after delayed diagnosis - BBC.com
Blood cancer: Man left with broken neck after delayed diagnosis BBC.com
Published: May 19, 2024, 7 a.m.
CoppaFeel: Woman 'blessed' to join breast cancer charity trek - BBC.com
CoppaFeel: Woman 'blessed' to join breast cancer charity trek BBC.com
Published: May 18, 2024, 7 a.m.
Plaintiffs Seek To Dismiss Hair Relaxer Lawsuits Involving Women Not Diagnosed with Uterine, Endometrial or Ovarian Cancer - AboutLawsuits.com
Plaintiffs Seek To Dismiss Hair Relaxer Lawsuits Involving Women Not Diagnosed with Uterine, Endometrial or Ovarian Cancer AboutLawsuits.com
Published: May 15, 2024, 8:32 p.m.
Revealed: people with cancer, arthritis and amputations among 40% denied disability benefits - The Guardian
Revealed: people with cancer, arthritis and amputations among 40% denied disability benefits The Guardian
Published: May 12, 2024, 7 a.m.
Olivia Munn, 43, reveals she had a hysterectomy during her battle with breast cancer: 'I had a real breakdown' - Daily Mail
Olivia Munn, 43, reveals she had a hysterectomy during her battle with breast cancer: 'I had a real breakdown' Daily Mail
Published: May 12, 2024, 7 a.m.
Dr Corr on the Rationale for Investigating Rucaparib Maintenance in Endometrial Cancer - OncLive
Dr Corr on the Rationale for Investigating Rucaparib Maintenance in Endometrial Cancer OncLive
Published: May 10, 2024, 7 a.m.
Merck's endometrial cancer therapy fails trial - Reuters
Merck's endometrial cancer therapy fails trial Reuters
Published: May 9, 2024, 7 a.m.
Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer - AJMC.com Managed Markets Network
Postsurgical Pembrolizumab and Chemo, With or Without Radiotherapy, Falls Short in Phase 3 Trial for Newly Diagnosed, High-Risk Endometrial Cancer AJMC.com Managed Markets Network
Published: May 9, 2024, 7 a.m.
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer - FiercePharma
Merck's Keytruda plus chemo comes up short as post-surgery therapy in newly diagnosed endometrial cancer FiercePharma
Published: May 9, 2024, 7 a.m.
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint - Healio
Phase 3 trial evaluating Keytruda in endometrial cancer misses primary survival endpoint Healio
Published: May 9, 2024, 7 a.m.
Link copied to clipboard!